Riley Hospital for Children/Indiana University

Indianapolis, Indiana 46202-5225

5 studies enrolling now · 23 studies all time

What they study most

AML, Childhood, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Adenovirus Infection, B-cell Acute Lymphoblastic Leukemia, Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Cystic Fibrosis, Cytomegalovirus Infections, Diabetes Mellitus, Type 1, EBV Infection

Studies at this site

• CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) — Recruiting now
• Streamlined Treatment of Pulmonary Exacerbations in Pediatrics — Recruiting now
• Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 — Recruiting now
• TrialNet Pathway to Prevention of T1D — Recruiting now
• The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL — Recruiting now
• Open-Label Study of 18F-mFBG for Imaging Neuroblastoma — Running, not enrolling
• LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis — Running, not enrolling
• Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children — Completed
• Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation — Running, not enrolling
• HPV Vaccine Hesitancy Among Indiana Youth With Cancer and Blood Diseases — Completed
• Investigating Interventions to Reduce Residual Opioids in the Home Following Legitimate Opioid Prescribing in Children. — Completed
• Exercise Intervention in Adolescent and Young Adult Cancer Survivors — Status unconfirmed
• Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors — Completed
• A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia — Stopped early
• Evaluation of an Exercise Intervention for Vincristine Induced Peripheral Neuropathy in Pediatric Cancer Patients — Completed
• Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) — Completed
• Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor — Completed
• Study of Imatinib in Children With Neurofibromatosis and Airway Tumors — Withdrawn before enrolling
• Pediatric Longitudinal Cohort Study of Chronic Pancreatitis — Completed
• MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia — Completed
• A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) — Stopped early
• Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT — Completed
• Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials — Completed